NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert

Read More
Media

Beyond Biotech Podcast: Mainz Biomed

Read More
Corporate News

Mainz Biomed Provides Year-End 2022 Corporate Review

Read More
Corporate News

Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert

Read More
Corporate News

Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study

Read More
Corporate News

Mainz Biomed Appoints Amy Levin as Vice President of Regulatory Affairs to Oversee Global Regulatory Strategies

Read More

If you would like to be kept up to date with the very latest news, please enter your details in the form and we will keep you updated.

  • This field is for validation purposes and should be left unchanged.